Intervencionismo Coronario en Venas Centrales

22_jorge_villegas
Jorge Villegas
2014-10-30

Cardiólogo Intervencionista
Profesor: F.U.C.S.
Jefe de Hemodinmia Hospital Universitario Clínica San Rafael

More articles by this author

Stroke

Rutger-Jan Nuis 2014-10-30MD, MSc, PhDDepartment of CardiologyThoraxcenter Rotterdam, Netherlands

TAVI-Induced Conduction Abnormalities

Rutger-Jan Nuis 2014-10-30MD, MSc, PhDDepartment of CardiologyThoraxcenter Rotterdam, Netherlands

In Perspective: Impact of new TAVI Devices on TAVI Complications

Eberhard Grube2014-10-30MD, FACC, FSCAIUniversity Hospital, Dept of Medicine II, Bonn, GermanyStanford University, Palo Alto, California, USA 

Orbital Atherectomy

Cesar E. Mendoza2014-10-30MDCardiovascular Disease DivisionJackson Memorial HospitalMiami, Florida

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...